Spark Therapeutics (ONCE) News Today → Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (From InvestorPlace) (Ad) Free ONCE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisHeadlinesSocial MediaStock AnalysisHeadlinesSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 8, 2024 | finance.yahoo.comQ1 2024 Travere Therapeutics Inc Earnings CallMay 2, 2024 | msn.comVerdict delivered on Steven Schumacher after half-a-season at Stoke City and candidates for player of the yearApril 29, 2024 | bizjournals.comFormer Spark Therapeutics exec sues company over alleged sexual discrimination, retaliationApril 23, 2024 | uk.news.yahoo.comVoyager 1: NASA's longest-running spacecraft back in touch with Earth after five months of silenceApril 7, 2024 | msn.comTotal eclipse sparks ‘once-in-a-lifetime’ parties across blackout zone: ‘All everyone is talking about’March 27, 2024 | mirror.co.ukSharon Osbourne takes another swipe at X Factor as she admits she's 'very much against' rebootMarch 16, 2024 | sg.finance.yahoo.comAries Season Is Here, and It's Time to Start FreshMarch 14, 2024 | finance.yahoo.comful. Health Introduces Innovative Solution to Help Group Health Plans Right-Size Healthcare SpendingMarch 13, 2024 | finance.yahoo.comFred L. Goldenberg: Drug prices out of controlMarch 5, 2024 | finance.yahoo.comOmega Park inaugurates the Makwa Foundation for the Conservation and Protection of Endangered SpeciesFebruary 28, 2024 | ca.news.yahoo.comViking Therapeutics' weight loss drug showed faster results in clinical trials than Ozempic or Wegovy. Here's how it works.February 27, 2024 | markets.businessinsider.comPliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial ResultsFebruary 24, 2024 | msn.comBig Money Is Taking Over MDMA-Assisted TherapyFebruary 23, 2024 | finance.yahoo.comPCM Trials Acquires EmVenio Research to Create the Most Patient-Centric Model for Hybrid and Decentralized Clinical TrialsFebruary 22, 2024 | msn.com10 Minor Unsolved Mysteries In The Legend of Zelda With Major ImplicationsFebruary 8, 2024 | msn.comMitochondrial misfire sparks inflammationFebruary 2, 2024 | finance.yahoo.comAgendia Announces First Patient Enrolled in DEBRA Trial Using MammaPrint®January 29, 2024 | finanznachrichten.deAdverum Biotechnologies, Inc.: Adverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific OfficerJanuary 28, 2024 | msn.comGene therapy for pets: French company buys start-up cofounded by Penn’s Jim WilsonJanuary 26, 2024 | bizjournals.comDr. Carl June on the next biotech breakthroughs and why Philadelphia will lead the wayJanuary 25, 2024 | markets.businessinsider.comBuy Rating Affirmed for Vera Therapeutics on Promising IgAN Drug Trial ResultsJanuary 23, 2024 | uk.finance.yahoo.comLeukemia Therapeutics Market: Robust Growth Expected with Innovative CAR-T TreatmentsJanuary 17, 2024 | finance.yahoo.comAward-Winning Biotech Training Program to Begin Recruitment with New Employer Partner in Life SciencesJanuary 7, 2024 | bizjournals.comAs Philadelphia life sciences projects slow, developers remain bullish on long-term outlookJanuary 2, 2024 | msn.comMicroRNA is the master regulator of the genome − researchers are learning how to treat disease by harnessing the way it controls genesJanuary 1, 2024 | msn.comOpinion: Bringing psychedelic medicine from the margins to the mainstreamDecember 27, 2023 | msn.com'Magical' Theme Park Date Sparks Couple GoalsDecember 26, 2023 | msn.comIn $4 billion deal, Bristol Myers Squibb to buy cancer therapeutics firm RayzeBioDecember 16, 2023 | finance.yahoo.comLVMH and luxury’s year of changing fortunes set for reverse act in 2024December 14, 2023 | msn.comWhat’s next for CRISPR? A Penn cardiologist wants to edit the genes of people with high cholesterol.December 4, 2023 | finance.yahoo.comSmart Immune appoints Dr. Rahim Fandi, M.D, PhD as Chief Medical Officer, strengthening C suite with seasoned oncology expertiseDecember 1, 2023 | finance.yahoo.comFoghorn Therapeutics Inc.'s (NASDAQ:FHTX) Price Is Right But Growth Is Lacking After Shares Rocket 27%December 1, 2023 | finance.yahoo.comAkari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of DirectorsNovember 28, 2023 | msn.comThe CRISPR Era Is HereNovember 24, 2023 | msn.comSchool Stabbing Sparks Unrest In Dublin, 34 Arrested For RiotingNovember 22, 2023 | cnet.comCapital One Spark Cash Select Review: Two Options for BusinessesNovember 21, 2023 | bizjournals.comUnpaid contractors file more than $125M in liens against Discovery Labs as MLP Ventures works to secure financingNovember 14, 2023 | msn.comLarimar Therapeutics GAAP EPS of -$0.21 beats by $0.02November 8, 2023 | msn.comJanux Therapeutics GAAP EPS of -$0.25November 8, 2023 | msn.comCrescita Therapeutics GAAP EPS of -C$0.06, revenue of C$3.03MOctober 9, 2023 | msn.comFutures down as Middle East conflict sparks run for safe-haven assetsOctober 9, 2023 | reuters.comUS STOCKS-Futures down as Middle East conflict sparks run for safe-haven assetsOctober 9, 2023 | ft.comCovid antivirals lose spark as regulatory scrutiny increasesSeptember 26, 2023 | finance.yahoo.comGene Therapy Market Size to Reach USD 35.1 Billion By 2032 CAGR: 16.4%. Report By DataHorizzon ResearchSeptember 14, 2023 | news.yahoo.comControversial park sign sparks divided reaction online: ‘I need a couple copies of this sign’September 12, 2023 | yahoo.com‘Pain Hustlers’ Review: Emily Blunt Dominates Netflix’s Simplistic Opioid DramaSeptember 8, 2023 | benzinga.comEXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System CancersSeptember 5, 2023 | markets.businessinsider.comSernova Corporation Announces the Appointment of Cynthia Pussinen as CEOSeptember 1, 2023 | msn.comFTSE 100 Live: London blue-chips climb amid big GDP revision, surprise jump in US unemploymentAugust 29, 2023 | benzinga.comSpark Biomedical Awarded $1.15M Department of Defense Phase II STTR Grant in Partnership with Battelle Memorial Institute Get Spark Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCE and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… ONCE Media Mentions By Week ONCE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONCE News Sentiment▼0.000.42▲Average Medical News Sentiment ONCE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONCE Articles This Week▼01▲ONCE Articles Average Week Get Spark Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SRNE News CELZ News TTNP News PALI News FRTX News TCON News IKT News ONVO News TCBP News KRBP News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONCE) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry ResearchCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spark Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
